278 related articles for article (PubMed ID: 27070647)
1. Neuromodulation and female pelvic disorders.
Noblett K
Curr Opin Urol; 2016 Jul; 26(4):321-7. PubMed ID: 27070647
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for explantation due to infection after sacral neuromodulation: a multicenter retrospective case-control study.
Myer ENB; Petrikovets A; Slocum PD; Lee TG; Carter-Brooks CM; Noor N; Carlos DM; Wu E; Van Eck K; Fashokun TB; Yurteri-Kaplan L; Chen CCG
Am J Obstet Gynecol; 2018 Jul; 219(1):78.e1-78.e9. PubMed ID: 29630890
[TBL] [Abstract][Full Text] [Related]
3. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
4. What Is New in Neuromodulation?
Moore CK; Rueb JJ; Derisavifard S
Curr Urol Rep; 2019 Aug; 20(9):55. PubMed ID: 31388779
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
[TBL] [Abstract][Full Text] [Related]
6. Sacral Nerve Stimulation as a Therapy for Patients With Refractory Voiding and Bowel Dysfunction.
Noblett KL; Buono K
Obstet Gynecol; 2018 Dec; 132(6):1337-1345. PubMed ID: 30399090
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
[TBL] [Abstract][Full Text] [Related]
8. Role of sacral neuromodulation in modern urogynaecology practice: a review of recent literature.
Tahseen S
Int Urogynecol J; 2018 Aug; 29(8):1081-1091. PubMed ID: 29302716
[TBL] [Abstract][Full Text] [Related]
9. Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction.
Noblett KL; Cadish LA
Am J Obstet Gynecol; 2014 Feb; 210(2):99-106. PubMed ID: 23899452
[TBL] [Abstract][Full Text] [Related]
10. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
11. The effect of pulse rate changes on the clinical outcome of sacral neuromodulation.
Marcelissen TA; Leong RK; Nieman FH; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2011 May; 185(5):1781-5. PubMed ID: 21420118
[TBL] [Abstract][Full Text] [Related]
12. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
Parnell BA; Howard JF; Geller EJ
Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
[TBL] [Abstract][Full Text] [Related]
13. Onset of Action of Sacral Neuromodulation in Lower Urinary Tract Dysfunction-What is the Optimal Duration of Test Stimulation?
Jairam R; Drossaerts J; Marcelissen T; van Koeveringe G; van Kerrebroeck P
J Urol; 2018 Jun; 199(6):1584-1590. PubMed ID: 29291416
[TBL] [Abstract][Full Text] [Related]
14. Neuromodulation in urology, state of the art.
Ammirati E; Giammò A; Manassero A; Carone R
Urologia; 2019 Nov; 86(4):177-182. PubMed ID: 31368415
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of sacral neuromodulation with the tined lead procedure.
Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
[TBL] [Abstract][Full Text] [Related]
16. Sacral neuromodulation in urological indications: the Finnish experience.
Vaarala MH; Tammela TL; Perttilä I; Luukkonen P; Hellström P
Scand J Urol Nephrol; 2011 Feb; 45(1):46-51. PubMed ID: 20961268
[TBL] [Abstract][Full Text] [Related]
17. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
Chartier-Kastler E
BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
[No Abstract] [Full Text] [Related]
18. Sacral Neuromodulation: Determining Predictors of Success.
Morgan TN; Pace N; Mohapatra A; Ren D; Kunkel G; Tennyson L; Shepherd JP; Chermansky CJ
Urology; 2021 Jul; 153():124-128. PubMed ID: 32619594
[TBL] [Abstract][Full Text] [Related]
19. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
Marinkovic SP; Ford JC
BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
[TBL] [Abstract][Full Text] [Related]
20. Sacral Nerve Stimulation for Pediatric Lower Urinary Tract Dysfunction: Development of a Standardized Pathway with Objective Urodynamic Outcomes.
Schober MS; Sulkowski JP; Lu PL; Minneci PC; Deans KJ; Teich S; Alpert SA
J Urol; 2015 Dec; 194(6):1721-6. PubMed ID: 26141849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]